-
The Pros and Cons of Using AI to Screen for Breast Cancer
18 Apr 2024 05:55 GMT
… minimizing false positives. Breast cancer is the second most common … women are diagnosed with breast cancer annually, according to the … women involved in the trial, the software detected six … which can result in unnecessary treatment. A 2022 Danish study …
-
NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients
18 Apr 2024 13:09 GMT
Researchers have used high-resolution gene expression data from individual tumor cells to fine-tune the ability of an AI tool called PERCEPTION to predict drug responses.
Credit: Created by Linda Wang with Biorender.com
What
In a proof-of-concept study, …
-
NI doctor Gerard Walls is researching how to help protect cancer patients' hearts during radiotherapy treatment
18 Apr 2024 11:15 GMT
… trial, (CORNCORDE) investigating if giving targeted cancer drugs alongside radiotherapy can improve treatment … cancer treatment.
Andrea was diagnosed with breast cancer in 2005 … treatments. Her cardiac diagnosis is now thankfully well managed with medication …
-
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
18 Apr 2024 07:34 GMT
… trial designed to evaluate the safety and efficacy of the drug … the only KRAS targeted treatments FDA approved in cancer. … cells. Cancer Chemother Pharmacol. 2006;57(2): … expression in breast cancer and its clinical significance. Breast Cancer Res. …
-
Immunotherapy shows promise for aggressive breast cancer
18 Apr 2024 01:26 GMT
… a phase II clinical trial to evaluate the safety … immunotherapy in aggressive forms of breast cancer. The study aims to … huge difference in my cancer treatment,” said Deborah Sumulong, a … including a large prospective clinical trial, is necessary to validate …
-
Younger Patients With HER2+ Breast Cancer May Benefit from Surgery First
17 Apr 2024 22:06 GMT
… postmenopausal women, regardless of treatment sequence with chemotherapy and surgery … HER2-positive, invasive, nonmetastatic breast cancer who received neoadjuvant chemotherapy or … result of the Alliance A11202 trial [NCT01901094], which [enrolls patients …
-
What Patients With Breast Cancer Need to Know About ADC-Related Fatigue
17 Apr 2024 21:29 GMT
Nearly 40% of patients with breast cancer treated with antibody-drug conjugates (ADCs) experienced fatigue, according to recently published study findings.
The study’s findings, published in Critical Reviews in Oncology/Hematology, analyzed data from 7 …
-
Estetrol by Mithra Pharmaceuticals for Genitourinary Syndrome of Menopause (GSM): Likelihood of Approval
18 Apr 2024 03:41 GMT
… development for the treatment of breast cancer, prostate cancer, vasomotor … treatment of osteoporosis, autoimmune disorders and migraine.
Mithra Pharmaceuticals overview
Mithra Pharmaceuticals … The company offers various drug products including Donesta, …
-
CDK4/6 Inhibitors as First-Line Options in Metastatic Breast Cancer
17 Apr 2024 16:38 GMT
… agents for patients with metastatic breast cancer. Dr. Keegan explains that City … demonstrated in the MONALEESA trial. The Monarch trial, which evaluated abemaciclib, … possible treatment outcomes.
*Video synopsis is AI-generated and reviewed by Pharmacy …
-
Pharmacists warn about nationwide drug shortage impacting patients
18 Apr 2024 01:24 GMT
… Pharmacists (ASHP) and Utah Drug Information Service.
“All drug … medications, including cancer chemotherapy drugs and emergency medications … . “Because the FDA says all generics are … treatments for a number of cancers, including triple-negative breast cancer …